This week’s EU health policy developments: cross-border healthcare, regulation of medicines and pesticides, and oversight of national recovery funds.
This week’s EU health policy developments: regulation and transparency for medicines; prevention for public health; safety for food and chemicals
This week’s EU health policy developments span youth mental health, medical device and chemical regulation, and environmental health — with new Commission answers on Lyme diagnostics, ethanol classification, and EU-US tariff exemptions for pharmaceuticals.
This week’s EU health policy developments range from cancer prevention and tobacco control to medical device reform, pesticide regulation, and healthcare workforce resilience. The Commission confirmed plans to revise the Medical Devices Regulation by end-2025, detailed actions on e-cigarettes and vector-borne diseases, and addressed chemical safety, cross-border health risks, and emergency access in an evolving digital and environmental landscape.
